However, because HαT significantly modifies clinical phenotypes associated with clonal MC disease, its increased prevalence among patients with SM may also reflect a detection bias, wherein those with both HαT and mastocytosis are more likely to come to medical attention because of increased symptom severity. The gene discussed is TMPRSS11D; the disease is systemic mastocytosis.